Cleveland Clinic Innovation Study Reveals Increased Concern for Dirty Stethoscopes, and Patient Preference For Novel Touch-Free Barrier Solution

The DiskCover System is a visible form of elevated patient protection that allows clinicians to make their stethoscopes touch-free in just 2 seconds.

Published by AseptiScope®

SAN DIEGO, Sep. 20, 2024

Amid increased patient concerns about hospitals ‘cleanliness’, as well as newly proposed 2024 stethoscope hygiene guidelines by the CDC, Cleveland Clinic researchers explored patient and provider preferences for various stethoscope hygiene methods. It turns out that patients and caregivers alike are concerned about stethoscope contamination, and patients rarely witness stethoscopes cleaning prior to the exam. This new study, titled “Patients and Healthcare Professionals’ Perceptions of Stethoscope Barriers” published today in the Online Journal of Issues in Nursing (OJIN), reveals new concerns for patient safety, and a common preference for a new solution; the touch-free DiskCover® System.  

Stethoscopes are now recognized as highly contaminated vectors that, just like the hands, share pathogens between each patient examination. In fact, stethoscopes are often referred to as the clinician’s “third hand” for their contamination levels and frequency of touching patients. Ostensibly, this means that stethoscope may be undermining all efforts of hand hygiene in healthcare.  With stethoscopes touching US patients over five billion times a year, it is conceivable that this vital medical device may be undermining infection control protocols everywhere. Touch-free, aseptic, stethoscope “disk cover” barriers are an established technology, with excellent clinical acceptance validated by multiple healthcare facilities in a broad range of clinical focuses across the nation. The study carried out by the Cleveland Clinic’s Nursing Innovation team aimed to find out patient perceptions of this novel solution to stethoscope hygiene.

This cross sectional study, surveyed 240 Cleveland Clinic patients and healthcare professionals who witnessed various methods for stethoscope hygiene.

Key findings indicate that patients rarely observe healthcare providers disinfecting their stethoscopes, with only 5% witnessing regular cleaning. The patient surveys also revealed:

  • They believe clean stethoscopes are important.
  • They rarely see clinicians cleaning stethoscopes.
  • Touch-free, disk cover barriers (The DiskCover System) were viewed positively by respondents.
The DiskCover System makes stethoscopes touch-free for patients.

The DiskCover System is a visible form of elevated patient protection that allows clinicians to make their stethoscopes touch-free in just 2 seconds.

Healthcare providers also favored The DiskCover System over alcohol cleaning of the stethoscope for its potential to enhance workflow, an ongoing infection control compliance factor for busy healthcare workers. They also believed that integrating touch-free barrier application into their hygiene practices would result in a greater improvement in patient satisfaction.

AseptiScope Co-Founder and CEO Scott Mader expressed enthusiasm about the study, stating, “The DiskCover System was designed to help busy clinicians while protecting patients.  However, this new data shows that in addition to actual patient protection, the visible disk cover barrier provides patient comfort that their healthcare provider is keeping them safe”.

In a healthcare environment where hospital-acquired infections remain a significant concern, The DiskCover System offers a bacteriologically impervious solution that is easier to use and more effective at delivering visual evidence of cleanliness, giving both patients and staff greater confidence in infection control practices. The study’s findings make a strong case for integrating The DiskCover System into routine care to safeguard patient health and elevate the patient experience, helping them feel more protected.

Patients come into the care of hospitals to heal, but contaminated stethoscopes and healthcare-associated infections (HAIs) have been a long-standing threat to this ideal. A report by Press Ganey, referencing patient experience data sourced from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS), found that the COVID-19 pandemic “created a dramatic shift in patient perceptions of hospital cleanliness.”

Patient perceptions for hospital hygiene have increased since the COVID-19 pandemic.
Source: Press Ganey, Emerging Best Practices in Response to Evolving Patient Perceptions of Clean. 2022.

Patient perceptions for hospital hygiene have increased since the COVID-19 pandemic. Source: Press Ganey, Emerging Best Practices in Response to Evolving Patient Perceptions of Clean. 2022.

Co-author W. Frank Peacock IV, MD, FACEP, FACC, FESC states, “This patient data aligns with Press Ganey research showing that demonstrations of protecting patients have become much more profound following COVID. Having a proven and visible safeguard for stethoscope hygiene is not only convenient and effective, but is something that comforts our patients as they receive care.”

This technology is increasingly being utilized in clinical care with real world commentary echoing what has been reinforced by Cleveland Clinic’s patients. Dr. Eric Crawley, a specialist at Hawaii Pacific Health, doesn’t need the study to see the impact on patient satisfaction. “I use this every single day, on every single patient, and, without fail, patients are blown away by it. They are incredibly impressed by our commitment to their safety. I deal with a considerable number of transplants, immuno-suppressed patients, and people that don’t need to pick up resistant pathogens.”

The DiskCover System is produced by AseptiScope, a medical device company based in San Diego, CA. AseptiScope, DiskCover, and related logos are registered trademarks of AseptiScope, Inc.

AseptiScope’s The DiskCover System Featured in IBT Media International Business Times

In The War Against Dangerous Pathogens In Hospitals, Healthcare Providers Elevate Patient Safety With Simple Solutions

Created by Karcy Noonan
Published 07/30/24 AT 11:30 AM EDT

A New Strategy to Protect Our Patients from Superbugs

In the autumn of 2019, at the largest infectious disease forum in the US, a group of medical experts met to discuss the challenge of Healthcare Associated Infection (HAI), which each year takes the lives of 100,000 US patients and costs providers billions of dollars. “We need a new strategy to protect our patients,” stated Frank Peacock, a widely published expert in infection control. and emergency medicine physician in Houston, Texas. Just a few months later, the world would come to a screeching halt with the greatest pandemic of the 21st century. Like all clinicians, Peacock would be thrown headfirst into a multi-year nightmare of long shifts, filled hospitals, and limited resources. The rest is of historical record.

Today, Frank Peacock still treats patients but is also the Chief Medical Officer at AseptiScope®, the company he co-founded with innovation experts who have produced novel solutions in areas like diabetes and cardiovascular disease for decades. “The greatest concern of HAI is that the bugs are winning” Peacock laments. Ever since the germ theory of disease became widely accepted in the late 19th century, clinicians have used various chemicals to kill pathogens, such as alcohol and antibiotics. However, these microorganisms are genetically diverse and are constantly evolving to survive against environmental pressures. This has led to the emergence of multidrug-resistant organisms, also known as “superbugs.” “We can’t wash our way out of this problem as these species learn to survive in the face of antimicrobials like alcohol. Recently, the CDC has elevated concerns that the stethoscope may be transmitting dangerous pathogens by touch between every patient. Touching US patients over 5 billion times a year, the stethoscope may be undermining patient safety. AseptiScope’s innovative solution, The DiskCover® System, blocks stethoscope transmission without contributing to increasing pathogen resistance” explains Peacock.

Resolving Unmet Challenges in Healthcare

AseptiScope CEO Scott Westhaver Mader uses a process he calls “Market-Driven Science,” to identify critical attributes required to resolve unmet challenges in healthcare. “Superbugs take the greatest toll on human life, so fighting them requires technologies that address both immediate needs and long-term impacts,” says Mader. “This touch-free technology provides clean patient contact, breaking transmission without evolving resistant species. Through the development of The DiskCover System, healthcare can win three battles in the war against microbes: improving patient safety, reducing the indiscriminate use of alcohol, and transitioning to sustainable technology.”

Having completed their design, development, and validation programs, co-founder and Chief Operations Officer Kelly Powers has led the operationalizing of the company. The first touch-free stethoscope hygiene system, The DiskCover System, is now registered with the FDA and the company is licensed to manufacture. “As anticipated, each production lot is bigger than the last. Our goal now is to sophisticate our approach to manufacturing as we expand our customer base and prepare to scale production for healthcare providers across the nation, who now finally have a true solution to this problem,” says Powers.

Authorities in Infection Control Recognize the Importance of Stethoscope Hygiene

The company now has attracted the attention of leaders in the field, some of the largest healthcare providers in the U.S., and a growing number of community hospitals and clinics. Top experts in infection control and patient care have recently called on the CDC to elevate the guidelines for stethoscope hygiene to the same level as hand hygiene, referring to the stethoscope as “the clinician’s third hand.” The authorities in infection control and medicine broadly have understood the nature of the problem with stethoscope transmission, but they lacked a true solution for this problem. “Now that The DiskCover System has been validated and is in use around the country, these experts are energized about resolving these patient safety challenges that have been suspected for decades and are now understood to be very real”, says Dr. Peacock. The CDC is issuing new 2024 guidelines designed to reduce the transmission of pathogens in healthcare, and with a completed framework requiring stethoscope hygiene between each patient encounter similar to hand hygiene.

“The DiskCover System is designed to block pathogen transmission while offering ease of use, workflow compatibility, sustainability, and a strong return on investment.” continues Mader. “We conduct studies published in our online clinical library, along with data showing clinical satisfaction data in hospitals, clinics, and more.”

AseptiScope, Inc. (www.aseptiscope.com) is a privately funded San Diego, California-based, clinical innovation portfolio company. AseptiScope, DiskCover, and associated logos are registered trademarks of AseptiScope, Inc.

______________________________________________________________________________

Article from International Business Times: https://www.ibtimes.com/war-against-dangerous-pathogens-hospitals-healthcare-providers-elevate-patient-safety-simple-3738473

AseptiScope, Inc. to Update Investors on the Emerging Growth Conference on May 9th, 2024

AseptiScope® invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.

San Diego, CA, May 2nd, 2024 / Digital Release / AseptiScope, Infection Prevention for Clinician and Patient (the “Company”) is pleased to announce that it will be giving an update on the Emerging Growth Conference on May 9th, 2024.

The next Emerging Growth Conference is presenting on May 9th, 2024. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s President & CEO, Scott Mader in real time.

To first view the Company’s previous presentations, visit:

https://www.youtube.com/watch?v=sVn3E-U1n_o

Mr. Mader will present an update and may subsequently open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and Mr. Mader will do his best to get through as many of them as possible.

AseptiScope Co-Founder & CEO, Scott Mader

AseptiScope will be presenting at 2:55 PM Eastern time for 12 minutes.

Please register here to ensure you are able to attend the conference and receive any updates that are released:

https://goto.webcasts.com/starthere.jsp?ei=1658202&tp_key=3a47c30b43&sti=aseptiscope

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference. We will release a link to that after the event.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

About AseptiScope, Inc.

AseptiScope, Inc. (www.aseptiscope.com), formed in early 2016, is a privately funded San Diego, California-based, clinical innovation company. The company is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that offer “Infection Protection for Clinician & Patient.”  The company has launched the first true and practical solution for the longstanding challenge of stethoscope contamination: The DiskCover System.  Visit www.diskcover.com for more information or https://store.aseptiscope.com to purchase directly.

AseptiScope’s flagship product, The DiskCover® System, makes stethoscopes touch-free for patients.

Disclosure

AseptiScope, DiskCover, and related logos are registered trademarks of AseptiScope, Inc.

Media Contact:

Name: Anthony Pham

Email: apham@aseptiscope.com